Effect of vitamin D supplementation on cardiac-metabolic risk factors in elderly : a systematic review and meta-analysis of clinical trials
© 2022. The Author(s)..
BACKGROUND: There has been a longstanding interest in the potential effect of vitamin D in preventing cardiac-metabolic diseases. However, there are divergent results regarding the impact of vitamin D supplementation (VDS) on managing cardiac-metabolic outcomes in the elderly population.
MATERIAL AND METHOD: We systematically searched electronic databases; Web of Science, PubMed, Scopus, EMBASE, Cochrane, and ProQuest. We included all trials that evaluated the effect of VDS on cardiac-metabolic risk factors in the elderly population, which were published until 30 September 2021. The effects of VDS on cardiac-metabolic outcomes were assessed using standardized mean difference (SMD). A random-effect model was used to pool the SMD and 95% confidence interval (CI).
RESULT: The literature search identified 4409 studies, of which 12 trials met inclusion criteria. Results of random effect meta-analysis indicated a significant reduction in total cholesterol (TC) (SMD: - 0.14 mg/dl; 95% CI: - 0.25, - 0.02) and triglyceride (TG) (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04) with VDS compared to the placebo. The subgroup analyses revealed that the reduction of TG in patients with diabetes and vitamin D deficiency was significant. Furthermore, short-term intervention (≤ 6 months) induced a significantly lower level of TG and insulin in comparison to longer duration (> 6 months).
CONCLUSION: The study suggests that VDS could improve insulin concentration and dyslipidemia in the elderly population. The systematic review was registered in Alborz university of medical sciences with 2060-01-03-1397 number and the Ethics council IR.ABZUMS.REC.1397.207 number.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Diabetology & metabolic syndrome - 14(2022), 1 vom: 25. Juni, Seite 88 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qorbani, Mostafa [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiac-metabolic |
---|
Anmerkungen: |
Date Revised 16.07.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1186/s13098-022-00859-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342738534 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342738534 | ||
003 | DE-627 | ||
005 | 20231226014818.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13098-022-00859-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1142.xml |
035 | |a (DE-627)NLM342738534 | ||
035 | |a (NLM)35752843 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Qorbani, Mostafa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of vitamin D supplementation on cardiac-metabolic risk factors in elderly |b a systematic review and meta-analysis of clinical trials |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a BACKGROUND: There has been a longstanding interest in the potential effect of vitamin D in preventing cardiac-metabolic diseases. However, there are divergent results regarding the impact of vitamin D supplementation (VDS) on managing cardiac-metabolic outcomes in the elderly population | ||
520 | |a MATERIAL AND METHOD: We systematically searched electronic databases; Web of Science, PubMed, Scopus, EMBASE, Cochrane, and ProQuest. We included all trials that evaluated the effect of VDS on cardiac-metabolic risk factors in the elderly population, which were published until 30 September 2021. The effects of VDS on cardiac-metabolic outcomes were assessed using standardized mean difference (SMD). A random-effect model was used to pool the SMD and 95% confidence interval (CI) | ||
520 | |a RESULT: The literature search identified 4409 studies, of which 12 trials met inclusion criteria. Results of random effect meta-analysis indicated a significant reduction in total cholesterol (TC) (SMD: - 0.14 mg/dl; 95% CI: - 0.25, - 0.02) and triglyceride (TG) (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04) with VDS compared to the placebo. The subgroup analyses revealed that the reduction of TG in patients with diabetes and vitamin D deficiency was significant. Furthermore, short-term intervention (≤ 6 months) induced a significantly lower level of TG and insulin in comparison to longer duration (> 6 months) | ||
520 | |a CONCLUSION: The study suggests that VDS could improve insulin concentration and dyslipidemia in the elderly population. The systematic review was registered in Alborz university of medical sciences with 2060-01-03-1397 number and the Ethics council IR.ABZUMS.REC.1397.207 number | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cardiac-metabolic | |
650 | 4 | |a Elderly | |
650 | 4 | |a Supplementation | |
650 | 4 | |a Vitamin D | |
700 | 1 | |a Zarei, Maryam |e verfasserin |4 aut | |
700 | 1 | |a Moradi, Yousef |e verfasserin |4 aut | |
700 | 1 | |a Appannah, Geeta |e verfasserin |4 aut | |
700 | 1 | |a Djalainia, Shirin |e verfasserin |4 aut | |
700 | 1 | |a Pourrostami, Kumars |e verfasserin |4 aut | |
700 | 1 | |a Ejtahed, Hanieh-Sadat |e verfasserin |4 aut | |
700 | 1 | |a Mahdavi-Gorabi, Armita |e verfasserin |4 aut | |
700 | 1 | |a Naderali, Ebrahim Khalil |e verfasserin |4 aut | |
700 | 1 | |a Khazdouz, Maryam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetology & metabolic syndrome |d 2009 |g 14(2022), 1 vom: 25. Juni, Seite 88 |w (DE-627)NLM192019317 |x 1758-5996 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:1 |g day:25 |g month:06 |g pages:88 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13098-022-00859-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 1 |b 25 |c 06 |h 88 |